sponsored byAAAS Golden Fund

EurekAlert!, a service of AAAS
Home About us
Advanced Search
22-Jul-2014 05:22
US Eastern Time

Username:

Password:

Register

Forgot Password?

Press Releases

Breaking News

Science Business

Grants, Awards, Books

Meetings

Multimedia

Science Agencies
on EurekAlert!

US Department of Energy

US National Institutes of Health

US National Science Foundation

Calendar

Submit a Calendar Item

Subscribe/Sponsor

Links & Resources

Portals

RSS Feeds

Accessibility Option On

Options

Portal Home

Glossary

Background Articles

Research Papers

Meetings

Links & Resources

Disease in the Developing World

News Releases

Key: Meeting M      Journal J      Funder F

Showing releases 1-25 out of 861.

1 | 2 | 3 | 4 | 5 > >>

Public Release: 21-Jul-2014
Nature Genetics
LSU's Mark Batzer contributes to Nature Genetics article on marmoset genome
LSU's Mark Batzer, Boyd Professor and Dr. Mary Lou Applewhite Distinguished Professor in Department of Biological Sciences in the College of Science, contributed to an article in the scientific journal Nature Genetics, titled 'The Common Marmoset Genome Provides Insight into Primate Biology and Evolution,' published on July 20.

Contact: Billy Gomila
bgomila@lsu.edu
225-578-3867
Louisiana State University

Public Release: 21-Jul-2014
Open Access Journal of Contraception
Communication about female condom vital to young adults, UT Arlington researchers say
UT Arlington communication researchers examine sexual health messages aimed at young college adults about the female condom.

Contact: Bridget Lewis
blewis@uta.edu
817-272-3317
University of Texas at Arlington

Public Release: 21-Jul-2014
The Lancet
Deaths and infections from HIV, tuberculosis, and malaria plummet globally
Today, fewer people are dying from HIV/AIDS, tuberculosis, and malaria, according to a new, first-of-its-kind analysis of trend data from 188 countries. The pace of decline in deaths and infections has accelerated since 2000, when the Millennium Development Goals were established to stop the spread of these diseases by 2015.

Contact: Rhonda Stewart
stewartr@uw.edu
206-897-2863
Institute for Health Metrics and Evaluation

Public Release: 21-Jul-2014
Proceedings of the National Academy of Sciences
Temple University researchers eliminate the HIV virus from cultured human cells for first time
The HIV-1 virus has proved to be tenacious, inserting its genome permanently into its victims' DNA, forcing patients to take a lifelong drug regimen to control the virus and prevent a fresh attack. Now, a team of Temple University School of Medicine researchers has designed a way to snip out the integrated HIV-1 genes for good.
National Institutes of Health

Contact: Jeremy Walter
Jeremy.Walter@tuhs.temple.edu
267-838-0398
Temple University Health System

Public Release: 17-Jul-2014
20th International AIDS Conference (AIDS 2014)
Biomarker discovery may lead to new HIV treatment
Further analysis of a Phase II study of therapeutic HIV vaccine candidate Vacc-4x revealed a potential biomarker associated with participants who experienced a more profound viral load reduction after receiving the vaccine. The results of this exploratory, ad hoc, subset analysis by St George's, University of London and Bionor Pharma were announced today at the AIDS 2014 Conference in Melbourne, Australia.
Bionor Pharma

Contact: David Sheon
dsheon@whitecoatstrategies.com
202-422-6999
WHITECOAT STRATEGIES, LLC

Public Release: 17-Jul-2014
Proceedings of the National Academy of Sciences
Eradicating fatal sleeping sickness by killing off the tsetse fly
Steven L. Peck, a BYU professor of biology, has lent his expertise in understanding insect movement to help shape a UN-sanctioned eradication effort of the tsetse fly -- a creature that passes the fatal African sleeping sickness to humans, domestic animals, and wildlife. Results of the effort appear in the Proceedings of the National Academy of Sciences.
US State Department, Joint Food and Agriculture Organization of the United Nations, International Atomic Energy Agency, Department of Technical Cooperation, Directorate of Veterinary Services of Senegal, Institut Senegalais de Recerches Agricoles

Contact: Todd Hollingshead
toddh@byu.edu
801-422-8373
Brigham Young University

Public Release: 16-Jul-2014
Analysis
Anti-tank missile detector joins the fight against malaria
State-of-the-art military hardware could soon fight malaria, one of the most deadly diseases on the planet. Researchers at Monash University and the University of Melbourne have used an anti-tank Javelin missile detector, more commonly used in warfare to detect the enemy, in a new test to rapidly identify malaria parasites in blood.

Contact: Lucy Handford
media@monash.edu
Monash University

Public Release: 16-Jul-2014
Food Control
Preventing foodborne illness, naturally -- with cinnamon
Cinnamomum cassia oil was shown to be effective as a natural antibacterial agent against several strains of Shiga toxin-producing Escherichia coli, known to the US Centers for Disease Control and Prevention as 'non-O157 STEC'. The study results add to a body of knowledge that will help improve food safety and reduce or eliminate cases of food poisoning and related deaths.

Contact: Meijun Zhu
meijun.zhu@wsu.edu
509-335-4016
Washington State University

Public Release: 15-Jul-2014
Talanta
New assay to spot fake malaria drugs could save thousands of lives
Chemists have created a new type of chemical test, or assay, that's inexpensive, simple, and can tell whether or not one of the primary drugs being used to treat malaria is genuine -- an enormous and deadly problem in the developing world. If widely used it could help save hundreds of thousands of lives.

Contact: Vincent Remcho
vincent.remcho@oregonstate.edu
541-737-8181
Oregon State University

Public Release: 15-Jul-2014
Nature Reviews Cardiology
Cardiac patients underserved globally due to lack of rehab programs: York University researcher
The article, Global availability of cardiac rehabilitation, published online at Nature Reviews Cardiology, indicates that while 68 per cent of high-income countries have cardiac rehabilitation, only 23 per cent of low-income and middle-income countries do, despite the fact that 80 per cent of deaths from heart disease occur in these countries.

Contact: Gloria Suhasini
suhasini@yorku.ca
416-736-2100 x22094
York University

Public Release: 15-Jul-2014
PLOS Medicine
Rollout strategy for diagnostic test in India may impact TB
Xpert MTB/RIF, a recently implemented tuberculosis (TB) test, has the potential to control the TB epidemic in India, but only if the current, narrow, implementation strategy is replaced by a more ambitious one that is better funded, also includes the private sector, and better referral networks are developed between public and private sectors, according to new research published in this week's PLOS Medicine.
Bill & Melinda Gates Foundation

Contact: Maya Sandler
medicinepress@plos.org
PLOS

Public Release: 14-Jul-2014
Emerging Infectious Diseases
Sierra Leone samples: Ebola evidence in West Africa in 2006
Analysis of clinical samples from suspected Lassa fever cases in Sierra Leone showed that about two-thirds of the patients had been exposed to other emerging diseases, and nearly nine percent tested positive for Ebola virus. The study, authored by USAMRIID and published in this month's edition of Emerging Infectious Diseases, demonstrates that Ebola virus has been circulating in the region since at least 2006 -- well before the current outbreak.
Armed Forces Health Surveillance Center, Global Emerging Infections Surveillance and Response System, US Department of Defense Cooperative Biological Engagement Program

Contact: Caree Vander Linden
teresa.l.vanderlinden.civ@mail.mil
301-619-2285
US Army Medical Research Institute of Infectious Diseases

Public Release: 10-Jul-2014
The Lancet
Injected vaccine could help eradicate polio
Re-introducing a type of polio vaccine that fell out of favor in the 1960s could hasten eradication of the disease, according to new research.
Bill & Melinda Gates Foundation

Contact: Sam Wong
sam.wong@imperial.ac.uk
44-207-594-2198
Imperial College London

Public Release: 9-Jul-2014
Cell Host & Microbe
The 'yin and yang' of malaria parasite development
'Herculean study' into malaria parasite development is completed -- bringing scientists closer to disrupting the life-cycle of this highly efficient parasite.
Medical Research Council

Contact: Lindsay Brooke
lindsay.brooke@nottingham.ac.uk
44-011-595-15751
University of Nottingham

Public Release: 4-Jul-2014
64th Lindau Nobel Laureate Meeting
Conclusion of the Lindau Nobel Laureate meeting
The 64th Lindau Nobel Laureate Meeting has ended with a panel discussion entitled 'Science for the benefit of mankind' on Mainau Island, Germany, today. In the panel discussion it was repeatedly emphasised that basic research forms the essential basis for applied science and should therefore be supported equally as translational research.

Contact: Christian Schumacher
christian.schumacher@lindau-nobel.org
49-838-227-73115
Lindau Meeting of Nobel Laureates

Public Release: 4-Jul-2014
The Obstetrician & Gynaecologist
Effects of conflict on women's reproductive health need to be managed sensitively
Clinicians need to be sensitive and aware of the unique challenges of women's reproductive health needs in times of conflict, suggests a new review published today in The Obstetrician & Gynaecologist.

Contact: Nicole Weingartner
sciencenewsroom@wiley.com
201-748-5808
Wiley

Public Release: 3-Jul-2014
Angewandte Chemie
Low-cost TB test means quicker, more reliable diagnosis for patients
A new test for tuberculosis developed at the Texas A&M Health Science Center could dramatically improve the speed and accuracy of diagnosis for one of the world's deadliest diseases, enabling health care providers to report results to patients within minutes, according to a study published this week in the journal Angewandte Chemie.
Wellcome Trust

Contact: Holly Lambert Shive
hlambert@tamhsc.edu
979-436-0613
Texas A&M University Health Science Center

Public Release: 1-Jul-2014
PLOS Biology
New compound blocks 'gatekeeper' enzyme to kill malaria
Melbourne researchers are homing in on a new target for malaria treatment, after developing a compound that blocks the action of a key 'gatekeeper' enzyme essential for malaria parasite survival. The compound, called WEHI-916, is the first step toward a new class of antimalarial drugs that could cure and prevent malaria infections caused by all species of the parasite, including those resistant to existing drugs.

Contact: Alan Gill
gill.a@wehi.edu.au
61-393-452-719
Walter and Eliza Hall Institute

Public Release: 30-Jun-2014
Proceedings of the National Academy of Sciences
Malaria parasite manipulates host's scent
Malaria parasites alter the chemical odor signal of their hosts to attract mosquitoes and better spread their offspring, according to researchers, who believe this scent change could be used as a diagnostic tool.
Bill and Melinda Gates Foundation Grand Challenges Exploration

Contact: A'ndrea Elyse Messer
aem1@psu.edu
814-865-9481
Penn State

Public Release: 30-Jun-2014
Women's groups recommended by WHO as an intervention to cut newborn deaths
The World Health Organisation has recommended an intervention developed and tested by partners in four countries and UCL researchers to improve maternal and newborn health.

Contact: Kate Hoyland
c.hoyland@ucl.ac.uk
University College London

Public Release: 30-Jun-2014
Sixth class of Global Health Corps fellows begin year of service to advance health equity
Global Health Corps welcomed its sixth class of fellows today at Yale University, for the opening of its annual Leadership Training Institute. Selected from a pool of nearly 5,000 applicants, the incoming class of fellows -- the largest ever -- reflects the growing enthusiasm and commitment of millennials to engage globally and address inequities worldwide. Representing 22 countries, GHC's newest class will begin their year of service within health organizations across Africa and the United States.

Contact: Ann Clark
ann.clark@edelman.com
212-704-8296
Edelman

Public Release: 30-Jun-2014
Proceedings of the National Academy of Sciences
Body odor reveals malarial infection
An infection with malaria pathogens changes the scent of infected mice, making those infected more attractive to mosquitos. These are the findings of a team of researchers from ETH Zurich and Pennsylvania State University in a new study.

Contact: Consuelo De Moraes
consuelo.demoraes@usys.ethz.ch
41-446-323-920
ETH Zurich

Public Release: 27-Jun-2014
Science
USAMRIID research sheds light on how deadly lassa virus infects cells
An international team of scientists has discovered that the Lassa virus, endemic to West Africa, uses an unexpected two-step process to enter cells. The results, published in today's edition of Science, suggest that the mechanism by which Lassa virus causes infection is more complicated than previously known, and could lead to new approaches for preventing the disease. Collaborators included USAMRIID, the Netherlands Cancer Institute, the University of Kiel in Germany, and Harvard Medical School.
Defense Threat Reduction Agency, European Research Council, National Institutes of Health

Contact: Caree Vander Linden
teresa.l.vanderlinden.civ@mail.mil
301-619-2285
US Army Medical Research Institute of Infectious Diseases

Public Release: 27-Jun-2014
64th Lindau Nobel Laureate Meeting
Global healthcare is a labour of Hercules
Swedish Professor for Global Health and YouTube star Hans Rosling to give presentation at the opening of the 64th Lindau Nobel Laureate Meeting in Germany on June 29.

Contact: Christian Schumacher
christian.schumacher@lindau-nobel.org
0049-838-227-73115
Lindau Meeting of Nobel Laureates

Public Release: 27-Jun-2014
Genome Biology
Scientists identify new pathogenic and protective microbes associated with severe diarrhea
Diarrhea is a major cause of childhood mortality in developing countries and ranks as one of the top four causes of death among young children in sub-Saharan Africa and South Asia. In a finding that may one day help control diarrhea, researchers have identified microorganisms that may trigger diarrheal disease and others that may protect against it. These microbes were not widely linked to the condition previously. The research results appear today in Genome Biology.
Bill & Melinda Gates Foundation, National Science Foundation, National Insitututes of Health, The Wellcome Trust

Contact: Tom Ventsias
tomvent@umiacs.umd.edu
301-405-5933
University of Maryland

Showing releases 1-25 out of 861.

1 | 2 | 3 | 4 | 5 > >>